vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and Nano Dimension Ltd. (NNDM). Click either name above to swap in a different company.

Nano Dimension Ltd. is the larger business by last-quarter revenue ($57.8M vs $38.9M, roughly 1.5× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs -171.1%, a 195.7% gap on every dollar of revenue. CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $-21.1M).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Nano Dimension Ltd. is a leading provider of additively manufactured electronics solutions and 3D printing technologies. It designs high-precision 3D printers, related materials, and software for producing printed circuit boards, microelectronics components, and multi-layer electronic devices, serving aerospace, defense, medical, automotive, and industrial electronics segments across global markets.

CDXS vs NNDM — Head-to-Head

Bigger by revenue
NNDM
NNDM
1.5× larger
NNDM
$57.8M
$38.9M
CDXS
Higher net margin
CDXS
CDXS
195.7% more per $
CDXS
24.7%
-171.1%
NNDM
More free cash flow
CDXS
CDXS
$40.7M more FCF
CDXS
$19.6M
$-21.1M
NNDM

Income Statement — Q4 FY2025 vs Q4 FY2024

Metric
CDXS
CDXS
NNDM
NNDM
Revenue
$38.9M
$57.8M
Net Profit
$9.6M
$-98.8M
Gross Margin
94.8%
43.1%
Operating Margin
27.1%
-155.1%
Net Margin
24.7%
-171.1%
Revenue YoY
81.3%
Net Profit YoY
192.5%
EPS (diluted)
$0.13
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
NNDM
NNDM
Q4 25
$38.9M
Q3 25
$8.6M
Q2 25
$15.3M
Q1 25
$7.5M
Q4 24
$21.5M
$57.8M
Q3 24
$12.8M
Q2 24
$8.0M
$28.4M
Q1 24
$17.1M
Net Profit
CDXS
CDXS
NNDM
NNDM
Q4 25
$9.6M
Q3 25
$-19.6M
Q2 25
$-13.3M
Q1 25
$-20.7M
Q4 24
$-10.4M
$-98.8M
Q3 24
$-20.6M
Q2 24
$-22.8M
$-79.2M
Q1 24
$-11.5M
Gross Margin
CDXS
CDXS
NNDM
NNDM
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
43.1%
Q3 24
66.4%
Q2 24
56.6%
45.8%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
NNDM
NNDM
Q4 25
27.1%
Q3 25
-220.3%
Q2 25
-83.9%
Q1 25
-271.6%
Q4 24
-34.2%
-155.1%
Q3 24
-129.0%
Q2 24
-284.9%
Q1 24
-69.6%
Net Margin
CDXS
CDXS
NNDM
NNDM
Q4 25
24.7%
Q3 25
-228.1%
Q2 25
-86.6%
Q1 25
-274.3%
Q4 24
-48.4%
-171.1%
Q3 24
-160.8%
Q2 24
-285.2%
-279.4%
Q1 24
-67.4%
EPS (diluted)
CDXS
CDXS
NNDM
NNDM
Q4 25
$0.13
Q3 25
$-0.22
Q2 25
$-0.16
Q1 25
$-0.25
Q4 24
$-0.12
$-0.45
Q3 24
$-0.29
Q2 24
$-0.32
$-0.35
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
NNDM
NNDM
Cash + ST InvestmentsLiquidity on hand
$78.2M
$317.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$860.0M
Total Assets
$147.8M
$902.5M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
NNDM
NNDM
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
$317.2M
Q3 24
$90.3M
Q2 24
$73.2M
$231.8M
Q1 24
$85.5M
Total Debt
CDXS
CDXS
NNDM
NNDM
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
NNDM
NNDM
Q4 25
$50.5M
Q3 25
$38.5M
Q2 25
$55.6M
Q1 25
$49.6M
Q4 24
$66.9M
$860.0M
Q3 24
$73.4M
Q2 24
$61.4M
$870.3M
Q1 24
$79.3M
Total Assets
CDXS
CDXS
NNDM
NNDM
Q4 25
$147.8M
Q3 25
$124.0M
Q2 25
$138.2M
Q1 25
$128.9M
Q4 24
$149.0M
$902.5M
Q3 24
$148.2M
Q2 24
$132.0M
$911.0M
Q1 24
$149.6M
Debt / Equity
CDXS
CDXS
NNDM
NNDM
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
NNDM
NNDM
Operating Cash FlowLast quarter
$20.1M
$-18.9M
Free Cash FlowOCF − Capex
$19.6M
$-21.1M
FCF MarginFCF / Revenue
50.3%
-36.5%
Capex IntensityCapex / Revenue
1.3%
3.8%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
NNDM
NNDM
Q4 25
$20.1M
Q3 25
$-7.7M
Q2 25
$-18.0M
Q1 25
$-13.8M
Q4 24
$-16.5M
$-18.9M
Q3 24
$-13.0M
Q2 24
$-12.2M
$-30.7M
Q1 24
$-7.8M
Free Cash Flow
CDXS
CDXS
NNDM
NNDM
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
$-21.1M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
CDXS
CDXS
NNDM
NNDM
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
-36.5%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
CDXS
CDXS
NNDM
NNDM
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
3.8%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
CDXS
CDXS
NNDM
NNDM
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons